PATENT CLAIM ANALYSIS

Application Number: 15866896
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["435", "325000"]

Abstract:
Described herein is a reliable method for preparing a potent vaccine useful for immunotherapy comprising the step of cryopreserving a population of cells undergoing immunogenic cell death, and using such cells to activate dendritic cells for use in immunotherapy. In a specific embodiment, the method comprises cryopreserving cancer cells undergoing cell death, which can be used to prepare a pharmaceutical composition for immunotherapy against cancer.

Claim (Index 29):
The population of animal cells of  claim 25 , wherein immunogenic cell death has been induced by high hydrostatic pressure, anthracyclines, anti-EGFR antibodies, Big Potassium channel antagonists, bortezomib, cardiac glycosides, cyclophosphamide, GADD43/PP1 inhibitors and mitomycin, irradiation by UV light or gamma rays, oxaliplatin, photodynamic therapy with hypericin, poly(I:C), or thapsigargin and cisplatin.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.52174
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14142448', '15388972', '12921708', '12384633', '14974357']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6111072451643282
- 35 USC 102 Novelty (BERT): 0.6285496979583413
- Combined Prediction Score: 0.6128514904437296
- Mean Citation Score: 397.26004
- Max Citation Score: 633.9658
- Similarity Product: 509.5713479746341

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test